Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study

BACKGROUND: Anti‐cancer vascular endothelial growth factor inhibitors (VEGFI) frequently induce a rise in blood pressure (BP). The most effective treatment of this BP rise is currently unknown, and risk factors and its association with survival remain inconclusive. METHODS AND RESULTS: Baseline char...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dorst, Daan C. H., Kabadayi, Sumeyye, Oomen‐de Hoop, Esther, Danser, A.H. Jan, Mathijssen, Ron H. J., Versmissen, Jorie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973592/
https://www.ncbi.nlm.nih.gov/pubmed/36583425
http://dx.doi.org/10.1161/JAHA.122.028050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973592/
https://www.ncbi.nlm.nih.gov/pubmed/36583425
http://dx.doi.org/10.1161/JAHA.122.028050

Ejemplares similares